1. Home
  2. IMCR vs LZB Comparison

IMCR vs LZB Comparison

Compare IMCR & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.63

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$37.50

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCR
LZB
Founded
2008
1927
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
IMCR
LZB
Price
$28.63
$37.50
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$66.33
$39.00
AVG Volume (30 Days)
304.3K
369.4K
Earning Date
05-07-2026
06-16-2026
Dividend Yield
N/A
2.75%
EPS Growth
30.39
N/A
EPS
0.25
1.65
Revenue
$249,428,000.00
$2,349,433,000.00
Revenue This Year
$14.57
$1.89
Revenue Next Year
$8.21
$2.09
P/E Ratio
$117.72
$22.70
Revenue Growth
43.05
N/A
52 Week Low
$27.56
$29.03
52 Week High
$40.71
$42.39

Technical Indicators

Market Signals
Indicator
IMCR
LZB
Relative Strength Index (RSI) 44.87 64.98
Support Level $27.69 $37.42
Resistance Level $31.56 $39.95
Average True Range (ATR) 1.14 1.00
MACD 0.08 0.24
Stochastic Oscillator 22.02 82.34

Price Performance

Historical Comparison
IMCR
LZB

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: